Overview

Comparison Between GLP 1 Analogues and DPP 4 Inhibitors in Type 1 Diabetes Mellitus

Status:
Completed
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
To study the effects of GLP 1 analogues and DPP 4 inhibitors on newly detected type 1 diabetes patients.
Phase:
Phase 4
Details
Lead Sponsor:
Command Hospital, India
Treatments:
Dipeptidyl-Peptidase IV Inhibitors
Exenatide
Insulin
Insulin, Globin Zinc
Sitagliptin Phosphate